Related Experiment Video
Updated: Feb 26, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Tuberculosis in Children
1Division of Infectious Diseases and International Health, University of Virginia, PO Box 801340, Charlottesville, VA 22908-1340, USA.
Insights
Accurate diagnosis of childhood tuberculosis (TB) remains a global challenge, impacting treatment and outcomes. New diagnostic tools are urgently needed to combat TB mortality in children worldwide.
Area of Science:
- Microbiology
- Pediatric Infectious Diseases
- Global Health
Background:
- Tuberculosis (TB) caused by Mycobacterium tuberculosis is a leading global cause of death.
- Annually, an estimated 1 million children worldwide contract TB, with many more in latent stages.
- Under-recognition and diagnostic challenges hinder accurate TB prevalence estimates in pediatric populations.
Purpose of the Study:
- To highlight the critical need for improved diagnostic methods for pediatric tuberculosis.
- To underscore the limitations of current diagnostic capabilities for confirming TB in children.
- To emphasize the urgency for advancements in TB diagnostics and treatment aligned with the End TB Strategy.
Main Methods:
- This study is a review and synthesis of current knowledge on pediatric tuberculosis diagnosis and treatment.
- It analyzes the impact of diagnostic challenges on disease burden and estimates.
- It discusses the implications of the End TB Strategy for childhood TB.
Main Results:
- Currently, no accurate diagnostic test exists to confirm TB in children.
- Diagnostic difficulties lead to under-recognition of TB cases in pediatric populations.
- Timely treatment initiation generally leads to favorable outcomes, but delays are common.
Conclusions:
- There is an urgent unmet need for accurate and accessible diagnostic tests for childhood tuberculosis.
- Improved diagnostics are essential to reduce the significant morbidity and mortality associated with TB in children.
- Advancements in diagnostics and treatment are crucial for achieving the goals of the End TB Strategy in pediatric populations.
Abstract:
Mycobacterium tuberculosis is the leading cause of death worldwide from a single bacterial pathogen. The World Health Organization estimates that annually 1 million children have tuberculosis (TB) disease and many more harbor a latent form. Accurate estimates are hindered by under-recognition and challenges in diagnosis. To date, an accurate diagnostic test to confirm TB in children does not exist. Treatment is lengthy but outcomes are generally favorable with timely initiation. With the End TB Strategy, there is an urgent need for improved diagnostics and treatment to prevent the unnecessary morbidity and mortality from TB in children.
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Other Pulmonary Disorders

